Magic mushroom therapy tested to soothe fear of death in cancer patients
NCT ID NCT06416085
Summary
This study is testing a new type of therapy that combines talk therapy with a single dose of psilocybin, the active compound in 'magic mushrooms.' It aims to help people with advanced cancer who are struggling with severe anxiety, depression, and fear related to their illness. The main goal is to see if this combined approach is safe, acceptable, and feasible for patients, and if it can improve their quality of life and ease their psychological suffering.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.